Events|

SHL Medical makes debut at ESBiomech 2024

Esb Website Press Release Inner Image
SHL Medical makes debut at ESBiomech 2024

SHL Medical is pleased to announce our presence at the 29th Congress of the European Society of Biomechanics (ESBiomech) at Edinburgh, Scotland, between June 30-July 3.

Following this year’s theme, “Biomechanics from research to practice”, we are excited to share our knowledge on the “Development of silicone-based test model for autoinjector functional performance analysis” by senior testing Dr. Paolo Ravaynia. This poster presentation offers audiences a look into SHL’s formation of a testing model that simulates human body injections via silicon material. Throughout the 4-day event, Paolo will be able to interact and share his expertise with visitors on-site.

As the leader in self-injection solutions, we look forward to sharing insights and engaging with new academic partners and industry professionals. The scientific nature of ESBiomech opens pathways for meaningful exchanges of knowledge on our journey to developing technological advancements within the autoinjector industry.

If you are interested in attending, please check out the official website to register.

Meet our presenter!

Title

Presenter

Date

Development of silicone-based test model for autoinjector functional performance analysis

Dr. Paolo Ravaynia

Senior Testing Engineer at SHL Medical

June 30 – July 3

When  : June 30 – July 3
Where : Edinburgh International Conference Centre (EICC), Edinburgh, UK

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News